11-hydroxyandrostenedione has been researched along with transforming growth factor beta in 1 studies
| Studies (11-hydroxyandrostenedione) | Trials (11-hydroxyandrostenedione) | Recent Studies (post-2010) (11-hydroxyandrostenedione) | Studies (transforming growth factor beta) | Trials (transforming growth factor beta) | Recent Studies (post-2010) (transforming growth factor beta) |
|---|---|---|---|---|---|
| 83 | 2 | 16 | 49,119 | 560 | 17,610 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernhardt, R; Defaye, G; Feige, JJ; Lenz, D; Liakos, P | 1 |
1 other study(ies) available for 11-hydroxyandrostenedione and transforming growth factor beta
| Article | Year |
|---|---|
Transforming growth factor beta1 inhibits aldosterone and cortisol production in the human adrenocortical cell line NCI-H295R through inhibition of CYP11B1 and CYP11B2 expression.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Analysis of Variance; Androstenedione; Angiotensin II; Colforsin; Corticosterone; Cortodoxone; Cytochrome P-450 CYP11B2; Depression, Chemical; Humans; Hydrocortisone; RNA, Messenger; Steroid 11-beta-Hydroxylase; Transforming Growth Factor beta; Tumor Cells, Cultured | 2003 |